Clinical Trial Detail

NCT ID NCT03303339
Title PCM-075 in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Trovagene, Inc.
Indications

acute myeloid leukemia

Therapies

Decitabine + Onvansertib

Cytarabine + Decitabine + Onvansertib

Cytarabine + Onvansertib

Age Groups: senior adult

No variant requirements are available.